High expression of the long isoform of TRAIL (TRAILL) in both subpopulations is significant, as this cytokine is under investigation as an anti-cancer agent [77] because it can selectively kill tumor cells via receptor-mediated apoptosis. This evidence concerns the gene TNFSF10 and cancer.